Perineural invasion by prostate adenocarcinoma in needle biopsies predicts bone metastasis: Ten year data from the TROG 03.04 RADAR Trial. Issue 2 (18th June 2020)

• Record Type: Journal Article
• Authors: Delahunt, Brett; Murray, Judith D; Steigler, Allison; Atkinson, Chris; Christie, David; Duchesne, Gillian; Egevad, Lars; Joseph, David; Matthews, John; Oldmeadow, Christopher; Samaratunga, Hemamali; Spry, Nigel A; Srigley, John R; Hondermarck, Hubert; Denham, James W
• Is Part Of: Histopathology. Volume 77:Issue 2(2020)
• Page Start: 284
• Page End: 292
• Publication Date: 2020-06-18
• Subjects: prostate adenocarcinoma -- perineural invasion -- prognosis -- metastases -- ISUP grade; Histology, Pathological -- Periodicals; 611.018
• DOI: 10.1111/his.14107
• Languages: English
• ISSNs: 0309-0167

Abstract

Abstract : Aims: Perineural invasion (PNI) by prostatic adenocarcinoma is debated as a prognostic parameter. This study investigates the prognostic predictive value of PNI in a series of patients with locally advanced prostate cancer treated with radiotherapy and androgen deprivation using 10 years outcome data from the TROG 03.04 RADAR trial. Methods: Diagnostic prostate biopsies from 976 patients were reviewed and the presence of PNI noted. Patients were followed for 10 years according to the trial protocol or until death. The primary endpoint for the study was time to bone metastasis. Secondary endpoints included time to soft tissue metastasis, transition to castration resistance, prostate cancer‐specific mortality and all‐cause mortality. Results: PNI was detected in 449 cases (46%), with 234 cases (24%) having PNI in more than one core. The presence of PNI was significantly associated with higher ISUP grade, clinical T staging category, National Comprehensive Cancer Network risk group, and percent positive biopsy cores. The cumulative probability of bone metastases according to PNI status was significant over the 10 years follow‐up interval of the study (log‐rank test P < 0.0001). PNI was associated with all endpoints on univariable analysis. After adjusting for baseline clinicopathological and treatment factors, bone metastasis was the only endpoint in which PNI retained its prognostic significance (hazard ratio 1.42, 95% confidence interval 1.05–1.92, P = 0.021). Conclusions: The association between PNI and the development of bone metastases supports the inclusion of this parameter as a component of the routine histology report. Further this association suggests that evaluation of PNI may assist in selecting those patients who should be monitored more closely during follow‐up.